P

Inventor

LONG YUN OLIVER

US25 patents
⚠️ This page may combine multiple inventors who share the name “LONG YUN OLIVER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARAXES PHARMA LLC

24 patents
US9840516B2Dec 12, 2017

Substituted quinazolines as inhibitors of KRAS G12C

ARAXES PHARMA LLC73 citations98
US10428064B2Oct 1, 2019

Fused-tricyclic inhibitors of KRAS and methods of use thereof

ARAXES PHARMA LLC27 citations94
US10414757B2Sep 17, 2019

2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof

ARAXES PHARMA LLC33 citations94
US10370386B2Aug 6, 2019

Substituted quinolines as inhibitors of KRAS G12C

ARAXES PHARMA LLC33 citations94
US10351550B2Jul 16, 2019

Substituted quinazoline compounds and methods of use thereof

ARAXES PHARMA LLC27 citations94
US10280172B2May 7, 2019

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC34 citations94
US10246424B2Apr 2, 2019

Substituted quinazoline compounds and methods of use thereof

ARAXES PHARMA LLC36 citations94
US10144724B2Dec 4, 2018

Substituted quinazoline compounds and methods of use thereof

ARAXES PHARMA LLC44 citations94
US9988357B2Jun 5, 2018

Methods for preparation of quinazoline derivatives

ARAXES PHARMA LLC38 citations93
US10975071B2Apr 13, 2021

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC9 citations86
US10927125B2Feb 23, 2021

Substituted cinnolines as inhibitors of KRAS G12C

ARAXES PHARMA LLC11 citations86
US10882847B2Jan 5, 2021

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC11 citations86
US10875842B2Dec 29, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC11 citations86
US10858343B2Dec 8, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC11 citations86
US10829458B2Nov 10, 2020

Substituted quinazoline compounds and methods of use thereof

ARAXES PHARMA LLC13 citations86
US10730867B2Aug 4, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC15 citations86
US10723738B2Jul 28, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC15 citations86
US10689356B2Jun 23, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC16 citations86
US10647703B2May 12, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC18 citations86
US11021470B2Jun 1, 2021

2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof

ARAXES PHARMA LLC8 citations84
US10011600B2Jul 3, 2018

Methods and compositions for inhibition of Ras

ARAXES PHARMA LLC12 citations84
US11878985B2Jan 23, 2024

Substituted quinazolines as inhibitors of KRAS G12C

ARAXES PHARMA LLC2 citations73
USRE50490EJul 15, 2025

Substituted quinazoline compounds and methods of use thereof

ARAXES PHARMA LLC0 citations63
US12234244B2Feb 25, 2025

Substituted piperazines as inhibitors of KRAS G12C

ARAXES PHARMA LLC0 citations63

LIGAND PHARM INC

1 patent